The company was founded in 2001 and is a national high-tech enterprise whose main business is R&D, production and sales of in vitro diagnostic products. It has a series of in vitro diagnostic products that are developing at the same time as the international community. As one of the leading enterprises in the domestic in vitro diagnosis industry, the company strives to build the best in vitro diagnostic testing platform. The main products are biochemical testing systems, blood clotting testing systems, luminescence detection systems, blood type testing systems, pathological testing systems, and liquid biopsy CTC. Corporate honors: In 2018, the company obtained and applied for a total of 16 patents. The subsidiary Meichuang has obtained 2 patents. A total of 16 products obtained approval to change registration certificates. Obtained 19 new product registration certificates. There are also 32 new products in the registration process. The national “863 Plan” project carried out under the auspices of the company was successfully completed. It won the “Top 500 Charitable Charity Companies in the Chinese Manufacturing Industry”.